Creative Biolabs uses the plaque assay as a foundational component of phage research methods because it links a visible lysis event to infectious bacteriophage activity under defined host and plating conditions. A well-controlled bacteriophage plaque assay can support clonal purification, titer estimation, host-range analysis, and comparison of phage preparations, but the reported PFU value remains conditional on the assay system.
A plaque assay distributes a diluted phage sample through a susceptible bacterial lawn. Infection begins at separate locations, and repeated cycles of replication and lysis create visible zones called plaques. When plaques arise from sufficiently separated infectious units, the count can be used to estimate plaque-forming units per milliliter (PFU/mL).
PFU is an operational measure of infectious activity, not a direct count of every physical particle. Damaged particles, noninfectious particles, aggregates, host restriction, and plating conditions can make total particle numbers differ from PFU. Comparisons are therefore most reliable when the same host, medium, agar formulation, incubation, dilution method, and counting rules are used.
In a double agar overlay assay, phage and host cells are mixed in soft top agar and spread over a nutrient base agar. The semisolid matrix limits bulk movement while permitting local diffusion of progeny phage. A susceptible host grows into a lawn; each productive infection focus expands through nearby cells and produces a cleared or turbid plaque.
Plaque morphology reflects more than phage identity. Adsorption rate, latent period, burst size, diffusion, receptor expression, bacterial growth, agar concentration, temperature, and depolymerase activity can influence plaque diameter, clarity, edge, and halo formation. Morphology is useful as a comparative observation under matched conditions, but it should not be treated as a stand-alone measure of potency.
Fig.1 Multiple bacteriophage-host pairs produce distinct plaque sizes and appearances in soft agar, emphasizing the need for matched assay conditions during plaque interpretation.1
Top-agar concentration is not universal. Softer agar can improve diffusion for some phages, while firmer overlays may produce smaller plaques. The selected formulation should be validated for the host-phage pair and kept constant across samples that will be compared.
Use institutionally approved biosafety procedures and trained personnel. This guide provides planning-level information, not an organism-specific standard operating procedure.
Prepare enough dilutions to avoid relying on a single plate. The expected titer may be uncertain, and both confluent lysis and zero-plaque plates provide limited quantitative information. Duplicate or triplicate plating helps distinguish counting variation from dilution or mixing errors.
Use a predefined countable range appropriate to the plate size, plaque diameter, and validated protocol. Common teaching guidance often cites approximately 30-300 plaques, but large plaques may require a lower upper limit and very small plaques may need image-assisted counting. Do not count a plate simply because it falls within a generic numerical range if plaques overlap or the lawn is uneven.
PFU/mL = number of plaques / (dilution plated × volume plated in mL)
Example: 86 plaques from a 10^-6 dilution plated at 0.1 mL gives 86 / (10^-6 × 0.1) = 8.6 × 10^8 PFU/mL. A tenfold dilution error or failure to convert microliters to milliliters produces a tenfold result error, so the dilution exponent and volume unit should be shown in the calculation record.
| Observation | Likely contributors | Focused response |
|---|---|---|
| No plaques | Low titer, resistant host, inactive culture, adsorption failure, or unsuitable conditions | Verify host growth and positive control; test lower dilutions and review storage and incubation. |
| Confluent lysis | Too concentrated a sample or high effective multiplicity | Plate additional tenfold dilutions and reduce the plated phage input. |
| Tiny or faint plaques | Limited diffusion, slow infection, dense lawn, high agar concentration, or short incubation | Confirm matched controls; evaluate validated agar, host density, and incubation adjustments. |
| Irregular plaques or halos | Depolymerase activity, uneven overlay, contamination, or mixed phage population | Re-purify a discrete plaque and compare morphology under standardized conditions. |
| Uneven lawn | Poor mixing, top agar setting too early, wet plate, or unhealthy host | Standardize mixing and pouring; use fresh plates and actively growing cells. |
| Variable replicates | Pipetting, incomplete mixing, dilution carryover, counting bias, or biological heterogeneity | Repeat the dilution series with calibrated equipment and independent plaque counts. |
Creative Biolabs reviews the entire dilution pattern, control performance, lawn quality, and plate images before interpreting a plaque assay result. A clean calculation cannot rescue a plate that failed the biological or procedural controls.
A plaque assay can support phage enumeration, clone isolation, host-range analysis, and kinetic characterization. Extend the assay with the services needed before or after plaque formation.
Quantify infectious phage particles, examine plaque morphology, and isolate discrete plaques using conditions adapted to the selected phage-host system.
Determine and compare infectious phage titers to support experimental standardization, amplification decisions, and downstream functional studies.
| Service | How It Supports the Workflow |
|---|---|
| Phage Isolation | Obtain candidate phages for plaque-based purification, enumeration, and characterization. |
| Direct Isolation of Phage | Recover phages directly from samples when expected phage abundance is sufficient for detection. |
| Enriched Isolation of Phage | Increase recovery of low-abundance phages through host-assisted enrichment before plaque analysis. |
| Phage Spot Test | Pre-screen potential phage-host combinations before running quantitative plaque assays. |
| Phage MOI Determination | Establish suitable phage-to-host input ratios for amplification and downstream infection experiments. |
| Service | How It Supports the Workflow |
|---|---|
| Phage Amplification | Expand plaque-purified phage clones to the working titers required for further studies. |
| Phage Purification | Remove host-cell components from amplified preparations before analytical or functional testing. |
| Enumeration and Detection of Infectious Phages | Quantify infectious particles using methods selected for the phage type and sample matrix. |
| Phage Host-Range Determination | Extend plaque-based testing across bacterial strains to define host susceptibility patterns. |
| One-Step Growth Curve of Phage | Use controlled infection studies to determine latent period and burst-related kinetic parameters. |
Need help optimizing plaque visibility, titer reproducibility, or downstream characterization? Discuss your assay with our phage specialists.
What does PFU mean?
What is a countable plaque range?
A countable range is the plaque-density interval in which individual plaques can be distinguished and the statistical uncertainty is acceptable. Although 30-300 plaques is a common general guideline, the usable range depends on plate area, plaque size, overlap, lawn quality, and the validated method. Large plaques may require fewer counts. The laboratory should define and document its own acceptance criteria.
Why are serial dilutions required?
Serial dilutions increase the chance of producing at least one plate with separated plaques. They also provide an internal check: plaque counts should generally decrease with greater dilution. A dilution series is more reliable than attempting to predict a single suitable concentration from an unknown sample. Careful mixing, fresh tips, correct transfer volumes, and clear labels are essential because dilution errors propagate directly into the PFU calculation.
How is a plaque assay different from a spot test?
A spot test places a small sample volume on a bacterial lawn and is useful for rapid detection or host-range screening. Clearing does not necessarily prove productive infection. A plaque assay distributes diluted infectious units through an overlay so separated plaques can be counted and isolated. It is the stronger method for PFU estimation, clonal plaque recovery, and confirming productive infection under the tested conditions.
Why are plaques sometimes unclear?
Turbid or poorly defined plaques can result from incomplete lysis, temperate behavior, low diffusion, a dense or unhealthy lawn, mixed populations, unsuitable agar concentration, short incubation, or contamination. Halos may reflect extracellular depolymerase activity rather than an expanding zone of infection. Interpretation should compare matched controls and repeat the assay after plaque purification or condition review when needed.
How should replicate variability be handled?
Calculate each replicate separately and inspect the plates before averaging. Large differences can arise from incomplete mixing, pipetting error, uneven lawns, plaque overlap, contamination, or true sample heterogeneity. Compare adjacent dilutions and control plates, repeat the assay when acceptance criteria are not met, and report the variability transparently. More decimal places do not improve a result derived from inconsistent biological replicates.
References:
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
